Mistrial declared in trial of alleged senior living serial killer
By
Lois A. Bowers
Nov 22, 2021
The judge presiding over the first capital murder trial of alleged senior living serial killer Billy Chemirmir declared a mistrial Friday after jurors continued to be deadlocked 11-1 after two days of...
Concerns raised about COVID-19 chronic olfactory dysfunction
Nov 19, 2021
“These data suggest an emerging public health concern of OD and the urgent need for research that focuses on treating COVID-19 COD,” the authors wrote.
Strong opioids no better for pain after surgery for fracture
Nov 18, 2021
“These findings suggest that ongoing strong opioid use after discharge from the hospital should not be supported,” the authors wrote.
Fewer deaths reported with enrollment in COVID-19 remote monitoring
Nov 18, 2021
The remote monitoring service, COVID Watch, reduced deaths at 30 and 60 days and was associated with presentation to the emergency department sooner.
FDA could approve Pfizer booster shots for all adults this week
Nov 17, 2021
More than 30 million Americans already have gotten booster shots.
Hypertension may increase risk for late-onset epilepsy
Nov 17, 2021
After adjustment for prevalent and interim stroke, the risk for developing epilepsy increased almost twofold.
Operator livelihood threatened: 52% of workers fall behind retirement saving plans
By
Kathleen Steele Gaivin
Nov 17, 2021
More than half of working Americans responding to a recent Bankrate survey say they are behind on saving for retirement, and many have dipped into their retirement savings early. That could mean less money...
Partnership creates employment pipeline for CCRC, career opportunities for at-risk students
By
Kimberly Bonvissuto
Nov 17, 2021
A Tulsa, OK, life plan / continuing care retirement community has found an innovative way to create an employment pipeline for its community while also helping at-risk high school students find healthcare...
Pfizer asks FDA for emergency approval of its COVID-19 antiviral pill
Nov 16, 2021
The request comes shortly after clinical trial testing the drug was halted early due to overwhelming evidence of its effectiveness.
ACR: Lupus patients can have low immune response to COVID-19 vaccines
Nov 15, 2021
Overall disease activity does not appear to change after vaccination, however.